SALT LAKE CITY - Recursion, a clinical stage company specializing in drug discovery technology, has announced the appointment of Robert Hershberg, M.D., Ph.D., as the new Chair of the Board. Dr.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results